Skip to the content

Board Members & Management Grid

"I would to thank our shareholders for their continued support and our employees all over the globe for their dedication, skills and professionalism that has brought BATM to this exciting position and will continue to move us toward growth and profitability. As always, we are committed to creating value for our shareholders in the years to come and look forward to continuing to report our progress."

Prof. Gideon Chitayat
Non-executive Chairman


Non-executive Chairman

Dr. Gideon Chitayat
Non-executive Chairman

Dr. Gideon Chitayat is the Chairman and CEO of GMBS Ltd Strategic Consulting Firm. He is currently a director of Delta Galil Industries, Paz Oil Company and Milissron Shopping malls. Dr. Chitayat has served as a director for Teva Israel Pharmaceutical Industries, Bank Hapoalim and Israel Aircraft Industries. He has provided consultancy services to the Board and Presidents of Companies. Dr. Chitayat holds a Ph.D. in Business & Applied Economics from the University of Pennsylvania and a Masters in Business & Applied Economics from the Hebrew University, Jerusalem and joined the Board of BATM in June 2010. The unexpired period of this director’s term is until September 2017 and the Company will propose this director for re-election as Chairman of the Board at the coming Annual General Meeting.


Founder & CEO

Zvi Marom
Founder & CEO

Dr. Zvi Marom founded BATM in 1992. He holds degrees in Engineering and Medicine. Prior to establishing BATM, he was the head of the Electronic faculty of the Israeli Open University and senior consultant to several industrial and academic institutions. He graduated in excellence from the naval academy and served in combat command posts. He was awarded the Techmark “Technology Man of the Year” award from the London Stock Exchange in 2000. He is currently a director of Shore Capital Group plc, a UK-listed company, and receives remuneration for his services.


Non-executive Senior Director
Avigdor Shafferman
Non-executive Senior Director

Dr. Avigdor Shafferman holds a Ph.D. in physical chemistry from the Hebrew University of Jerusalem. He has served for the past eighteen years as general manager and Head of R&D of a leading governmental applied research institute specialising in the fi elds of biology, medicinal chemistry and environmental sciences. He was a visiting professor in the University of California, San Diego at the biology department as well as a visiting senior research scientist at various leading research institutions in the United States in various medical areas including vaccines.


Non-executive External Director
Harel Locker
Non-executive External Director

Harel Locker holds an LL.B. degree from Tel Aviv University’s School of Law (1994), a B.A. degree in accounting from Tel Aviv University Business School (1994) and an LL.M. (with distinction) in taxation from Georgetown University Law School, Washington DC (2001). Mr. Locker has wide experience in law and finance with first tier law firms in both Tel Aviv and New York, including Danziger, Clagsbald & Co., Law Firm, Tel Aviv, Israel; Fried, Frank, Harris, Shriver & Jacobson LLP, New York, N.Y. (2001-2004); Shohat, Locker &Co., Law Firm (2005-2007); and S. Friedman & Co., Law Firm (2007-2011). He was appointed and served as the Director General of the Israeli Prime Minister’s Office and head of Prime Minister Benjamin Netanyahu’s economic headquarters, between 2011 and 2015. He is currently the sole owner and director of his consultancy and investments company, Pitkrai Investments Ltd, and he is currently an external director of Matomy Media Group Ltd. (LSE: MTMY). Mr. Locker was appointed to the Board of BATM in September 2016.


Non-executive External Director
Orna Pollack
Non-executive External Director

Orna Pollock has extensive experience of more than twenty years in senior management positions in the fields of biotechnology, medical diagnostics, medical devices and clinical laboratory automation. Mrs. Pollack holds a B.Sci degree from the Hebrew University of Jerusalem and a Masters in Science degree in biochemistry from the Hebrew University of Jerusalem. She currently holds the position of CEO of Galmedics Biotechnologies and previously held CEO or similar level executive positions in well-known medical biotech companies, such as MicroMedic Technologies (TASE: MCTC), AgroGreen and Gamidor Diagnostics. Mrs Pollack was appointed to the Board in September 2015.


Executive Director & CFO
Moti Nagar
Executive Director & CFO

Moti Nagar joined BATM in 2014. Previously, Mr. Nagar held several management positions in Deloitte. As Senior Manager at Deloitte, he interfaced and handled the engagement relationships with leading corporate global clients, including companies traded on the LSE, NASDAQ, TSE and large private companies in the fields of industry, services, energy and holding companies. Mr. Nagar also led and supported public offerings of corporations in Israel and provided advice on taxation, including international taxation. Mr. Nagar graduated in Business Management and Accounting and qualified as an Israeli certified Accountant (CPA, Israel) in 2008. He also holds an MBA in Financial Management from Tel Aviv University. 


COO
Ofer Barner
COO of Medical Division

Ofer Bar-Ner, COO of Medical Division, joined BATM in 1999. From 1996 he was Chief Financial Officer of Silver Arrow LP, a subsidiary of Elbit Systems and EL-OP, and between 1989 and 1993 he was group manager in the finance department of Elbit. He graduated in Industrial Engineering and Management from the Technion in Haifa and has an MBA and MA in accounting from Northeastern University in Boston, MA.


COO
Ariel Efrati
COO of Telecom Division & CEO of Telco Systems


Ariel Efrati is the Chief Operating Officer of BATM, where he oversees BATM’s global business operations and telecommunications practices, and acts as Chief Executive Officer for Telco Systems, a BATM wholly owned subsidiary. Previously, Ariel held several senior positions in the telecom industry. As Senior Vice President, Ariel led Amdocs (NYSE:DOX) Venture Investments, Open Innovation and Product M&A unit, he headed Amdocs corporate competitive strategy unit, and he was the General Manager of the Service Fulfillment Product Business Division. Ariel also led Amdocs strategic and substantial entry to the OSS markets through organic growth and M&A activities. Ariel was the CEO of CallmyName, a startup in the Mobile sphere, and is a member of several successful startups’ BoDs, and is highly experienced in technological and market innovations. In the past, as a senior officer, Ariel led an advanced technological unit in the Israel Defense Forces (IDF) Intelligence Corps.  Ariel is a software engineer and an EMBA graduate of the Kellogg School of Management (Northwestern University).